Resolution of Refractory Eosinophilic Esophagitis with the Leukocyte-Trafficking Inhibitor Natalizumab

Dig Dis Sci. 2019 Sep;64(9):2688-2689. doi: 10.1007/s10620-019-05704-5. Epub 2019 Jun 12.

Author

Ian L P Beales¹

Affiliation

¹ Department of Gastroenterology, Norfolk and Norwich University Hospital, Norwich, NR4 7UY, UK. i.beales@uea.ac.uk.

PMID: 31190203
DOI: 10.1007/s10620-019-05704-5

No abstract available

Publication types

Letter
Comment

MeSH terms

Adrenal Cortex Hormones
Antibodies, Monoclonal, Humanized
Enteritis
Eosinophilia
Eosinophilic Esophagitis*
Gastritis
Humans
Leukocytes
Natalizumab

Substances

Adrenal Cortex Hormones
Antibodies, Monoclonal, Humanized
Natalizumab
vedolizumab

Supplementary concepts

Eosinophilic enteropathy